Bloudickova S - Search Results

1

Effect of inhibition of neuronal nitric oxide synthase and L-arginine supplementation on renal ischaemia-reperfusion injury and the renal nitric oxide system.

Rusai K, Fekete A, Szebeni B, Vannay A, Bokodi G, Müller V, Viklicky O, Bloudickova S, Rajnoch J, Heemann U, Reusz G, Szabó A, Tulassay T, Szabó AJ. Rusai K, et al. Among authors: bloudickova s. Clin Exp Pharmacol Physiol. 2008 Oct;35(10):1183-9. doi: 10.1111/j.1440-1681.2008.04976.x. Epub 2008 Jun 1. Clin Exp Pharmacol Physiol. 2008. PMID: 18518882

2

Regulators of angiogenesis in renal ischemia/reperfusion injury in normotensive and hypertensive rats: effect of tacrolimus.

Rajnoch J, Lodererova A, Szabo A, Honsova E, Vannay A, Bloudickova S, Matl I, Viklicky O. Rajnoch J, et al. Among authors: bloudickova s. Transplant Proc. 2005 Jan-Feb;37(1):352-4. doi: 10.1016/j.transproceed.2004.12.154. Transplant Proc. 2005. PMID: 15808641

3

Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat.

Bloudícková S, Rajnoch J, Lodererová A, Honsová E, Viklický O. Bloudícková S, et al. Kidney Blood Press Res. 2006;29(1):60-6. doi: 10.1159/000092948. Epub 2006 Apr 26. Kidney Blood Press Res. 2006. PMID: 16645304

4

Leflunomide derivate FK 778 in accelerated renal injury in transgenic rat.

Bloudícková S, Rajnoch J, Lodererová A, Honsová E, Viklický O. Bloudícková S, et al. Folia Biol (Praha). 2010;56(2):72-7. Folia Biol (Praha). 2010. PMID: 20492759 Free article.

5

New immunosuppressive agents in chronic progressive glomerulopathies: an update.

Bloudícková S, Viklický O. Bloudícková S, et al. Prague Med Rep. 2004;105(3):261-9. Prague Med Rep. 2004. PMID: 15782552 Review.

6

Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls.

Hubacek JA, Bloudickova S, Kubinova R, Pikhart H, Viklicky O, Bobak M. Hubacek JA, et al. Among authors: bloudickova s. Biochem Genet. 2009 Oct;47(9-10):688-93. doi: 10.1007/s10528-009-9266-y. Epub 2009 Jun 30. Biochem Genet. 2009. PMID: 19565203 Free PMC article.

7

The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population.

Hubacek JA, Viklicky O, Dlouha D, Bloudickova S, Kubinova R, Peasey A, Pikhart H, Adamkova V, Brabcova I, Pokorna E, Bobak M. Hubacek JA, et al. Among authors: bloudickova s. Nephrol Dial Transplant. 2012 Mar;27(3):1030-5. doi: 10.1093/ndt/gfr418. Epub 2011 Jul 25. Nephrol Dial Transplant. 2012. PMID: 21788373 Free PMC article. Clinical Trial.

8

Polymorphisms in IFN-γ, TNF-α and IL-10 in patients on maintenance haemodialysis.

Bloudíčková S, Kuthanová L, Hubáček JA. Bloudíčková S, et al. Folia Biol (Praha). 2011;57(1):30-4. Folia Biol (Praha). 2011. PMID: 21457652 Free article.

9

MTHFR and HFE, but not preproghrelin and LBP, polymorphisms as risk factors for all-cause end-stage renal disease development.

Bloudíčková S, Kuthanová L, Hubáček JA; MIA group. Bloudíčková S, et al. Folia Biol (Praha). 2014;60(2):83-8. Folia Biol (Praha). 2014. PMID: 24785111 Free article.

10

Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients.

Hubacek JA, Bloudícková S, Bohuslavová R, Táborský P, Polakovic V, Sazamová M, Svítilová E, Vlasák J, Sojková I, Ryba M, Knetl P, Ullrych M, Drahozal R, Pavuková V, Pavlíková B, Fischlová D, Mokrejsová M, Chmelícková H, Pauchová E, Vyskocil P, Nýdlová Z, Kopenec J, Fixa P, Hajný J, Bubenícek P, Syrovátka P, Zahálková J, Surel S, Hobzek Z, Hrubý A, Suchanová J, Vanková S, Brabcová J, Viklický O; MIA Group. Hubacek JA, et al. Among authors: bloudickova s. Clin Chem Lab Med. 2007;45(9):1121-3. doi: 10.1515/CCLM.2007.141. Clin Chem Lab Med. 2007. PMID: 17635077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page